Baricitinib Shows Long-Term Efficacy for Atopic Dermatitis
Patients who received 2 mg or 4 mg of baricitinib maintained vIGA-AD scores through 68 weeks of treatment.
Researchers Explore Unmet Needs for IBD Patients
The presence of extra-intestinal manifestations in biologic-naïve anti-TNF patients with Crohn’s disease was a predictor of disease severity.
Patients Report High Satisfaction with Depot Buprenorphine Treatment for Opioid Dependence
A new study compares patients self-reported outcomes after depot or daily sublingual buprenorphine treatment, including satisfaction and burden rates.
Direct-Acting Antivirals Effective Against HCV Following Liver Transplant Surgery
The majority of adverse effects reported were considered mild.
In-Human Gene Therapy BAY 2599023 Effective in Patients with Severe Hemophilia
A new study presented at ASGCT found that patients with indications of hemostatic efficacy experienced few adverse effects with gene therapy treatment BAY 2599023.
